2m 2m 2m 2m 2m 2m 2m
SUMMIT THERAP (SMMT)
NASDAQ
$14.25-$0.03 (-0.20%)
Price as of Jun 23, 2026 5:55 PM EDT- $11.1BMarket Cap
- -29.97%1-Year Change
- BiotechnologyIndustry
SUMMIT THERAP (SMMT)
$14.25-$0.03 (-0.20%)
SMMT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $14.28 | ||
Change | +$0.53 (+3.85%) | ||
Open | $13.78 | ||
High | $14.40 | ||
Low | $13.70 | ||
Previous Close | $13.75 | ||
Volume | 7,392,683 | ||
30-Day Average Volume | 7,337,806 | ||
1-Week Change | 1.06% | ||
1-Month Change | -14.08% | ||
1-Year Change | -29.97% | ||
3-Year Change | 413.67% | ||
5-Year Change | 117.68% | ||
Fundamentals | |||
Shares Outstanding | 776.2M | ||
Total Assets | $647.9M | ||
Market Cap | $11.1B | ||
Enterprise Value | $11.0B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$189.4M | ||
Free Cash Flow | -$122.5M | ||
EBIT | -$189.4M | ||
EBITDA | -$189.4M | ||
Net Working Capital | $533.3M | ||
EPS | -$0.24 | ||
Enterprise Value/EBITDA | -58 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 20 | ||
P/E | -60 | ||
PEG | -4 | ||
Price/Free Cash Flow | -90 | ||
Price/Operating Cash Flow | -91 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue